menu Search
Imojev

Imojev

japanese encephalitis vaccine

Manufacturer:

Sanofi Pasteur

Distributor:

Zuellig
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Live, attenuated, recombinant Japanese encephalitis virus (propagated in Vero cells)
Indications/Uses
Prophylaxis of Japanese encephalitis caused by Japanese encephalitis virus in patients ≥9 mth.
Click to view Imojev detailed prescribing information
Dosage/Direction for Use
SC Primary immunization Childn ≥9 mth 0.5 mL as single dose. Booster dose Adult No need for booster dose up to 5 yr after 1st vaccination. Childn & adolescent up to 18 yr 0.5 mL 1-2 yr after 1st vaccination.
Click to view Imojev detailed prescribing information
Overdosage
View Imojev overdosage for action to be taken in the event of an overdose.
Contraindications
History of severe allergic reaction to any vaccine component or after previous administration of the vaccine or vaccine containing the same components. Postpone vaccination in case of febrile or acute disease. Congenital or acquired immune deficiency impairing cellular immunity including immunosuppressive therapies eg, chemotherapy & high-dose systemic corticosteroids given ≥14 days. Symptomatic HIV infection or asymptomatic HIV infection accompanied by impaired immune function. Pregnancy & lactation.
Click to view Imojev detailed prescribing information
Special Precautions
Should not be administered by intravascular inj. Advisable to wait for ≥1 mth following interruption of high dose systemic corticosteroid therapy (given for ≥14 days) before carrying out vaccination.
Click to view Imojev detailed prescribing information
Use In Pregnancy & Lactation
Click to view Imojev detailed prescribing information
Adverse Reactions
Malaise, inj site pain; headache; myalgia. Inj site swelling. Adults: Fatigue. Feeling hot, chills, inj site erythema, pruritus, bruising; dizziness; arthralgia; diarrhoea, nausea, abdominal pain, vomiting; pharyngolaryngeal pain, dyspnea, rhinorrhea, cough, wheezing, nasal congestion; rash. Childn: Pyrexia, irritability, inj site tenderness, erythema; somnolence; vomiting; loss of appetite; crying.
Click to view Imojev detailed prescribing information
Drug Interactions
Separate inj sites & syringes when other vaccines are concomitantly administered. Do not mix w/ any other injectable vaccines or medicinal products. Vaccination must not be performed w/in 6 wk & preferably not w/in 3 mth of inj of Ig or blood products containing Ig eg, blood or plasma. Avoid contact w/ disinfectants. Concomitant use w/ immunosuppressive or corticosteroid therapy.
Click to view Imojev detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Imojev detailed prescribing information
Storage
View Imojev storage conditions for details to ensure optimal shelf-life.
Description
View Imojev description for details of the chemical structure and excipients (inactive components).
Action
View Imojev mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BA03 - encephalitis, Japanese, live attenuated ; Belongs to the class of encephalitis viral vaccines.
Regulatory Classification
Rx
Presentation/Packing
Form
Imojev powd for susp for inj 0.5 mL
Packing/Price
(+ diluent) 1's